鼻咽癌是我国常见的恶性肿瘤之一,标准治疗方法是放疗但对于Ⅲ,Ⅳ期中晚期患者,单纯放疗效果欠佳,局部复发率和远处转移率较高。因此,对中晚期鼻咽癌目前以放化综合治疗为主。根据放疗与化疗不同的结合方式,可以分为诱导化疗,同期放化疗和辅助化疗。较多前瞻性研究结果表明[1], Nasopharyngeal carcinoma is one of the common malignant tumors in our country. The standard treatment is radiotherapy. However, for patients with advanced stage Ⅲ and Ⅳ, radiotherapy alone is ineffective, and local recurrence rate and distant metastasis rate are higher. Therefore, the nasopharyngeal carcinoma of the current comprehensive treatment of radiotherapy. According to different combination of radiotherapy and chemotherapy, it can be divided into induction chemotherapy, concurrent chemoradiotherapy and adjuvant chemotherapy. More prospective studies have shown that [1],